These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 34483761)

  • 21. Tolerability of atypical antipsychotics.
    Stanniland C; Taylor D
    Drug Saf; 2000 Mar; 22(3):195-214. PubMed ID: 10738844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats.
    Porter JH; Prus AJ; Vann RE; Varvel SA
    Psychopharmacology (Berl); 2005 Feb; 178(1):67-77. PubMed ID: 15316715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminative stimulus properties of the typical antipsychotic haloperidol compared to other antipsychotic drugs in C57BL/6 mice.
    Donahue TJ; Webster KA; Hillhouse TM; De Oliveira EO; Porter JH
    Behav Pharmacol; 2019 Sep; 30(6):521-528. PubMed ID: 31058657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs.
    Atkins JB; Chlan-Fourney J; Nye HE; Hiroi N; Carlezon WA; Nestler EJ
    Synapse; 1999 Aug; 33(2):118-28. PubMed ID: 10400890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic mechanisms as targets for existing and novel antipsychotics.
    Meltzer HY
    Handb Exp Pharmacol; 2012; (212):87-124. PubMed ID: 23129329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.
    Weiner I
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):257-97. PubMed ID: 12601500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
    Miller DS; Yatham LN; Lam RW
    J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors.
    Bortolozzi A; Masana M; Díaz-Mataix L; Cortés R; Scorza MC; Gingrich JA; Toth M; Artigas F
    Int J Neuropsychopharmacol; 2010 Nov; 13(10):1299-314. PubMed ID: 20158933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats.
    Horiguchi M; Huang M; Meltzer HY
    Psychopharmacology (Berl); 2011 Sep; 217(1):13-24. PubMed ID: 21432027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
    Ichikawa J; Dai J; O'Laughlin IA; Fowler WL; Meltzer HY
    Neuropsychopharmacology; 2002 Mar; 26(3):325-39. PubMed ID: 11850147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
    Toren P; Ratner S; Laor N; Weizman A
    Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T; Bonsack C
    Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haloperidol and atypical antipsychotics share a same action of decreasing P75(NTR) mRNA levels in PC12 cells.
    Bai O; Xu H; Li XM
    Life Sci; 2006 Jul; 79(6):570-4. PubMed ID: 16513140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
    Woodward ND; Purdon SE; Meltzer HY; Zald DH
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):457-72. PubMed ID: 15784157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia.
    Meltzer HY; Massey BW; Horiguchi M
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1572-86. PubMed ID: 22283753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic drugs in bipolar disorder.
    Ertugrul A; Meltzer HY
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):277-84. PubMed ID: 12974994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical antipsychotics produce within-session decrements on self-stimulation of the rat medial prefrontal cortex.
    Montes MI; Chaatouf el H; Ferrer JM
    Front Biosci; 2005 Sep; 10():2595-603. PubMed ID: 15970521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear.
    Inoue T; Tsuchiya K; Koyama T
    Pharmacol Biochem Behav; 1996 Oct; 55(2):195-201. PubMed ID: 8951954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
    Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
    Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.